TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says November 29, 1996